BioSpace News Archive

GRI Bio, Inc. announced its new corporate branding and launch of its new corporate website, gribio.com.

Feldan Therapeutics, a biopharmaceutical company that specializes in the development of treatments based on intracellular delivery of therapeutics, has announced the initial closing of a $16.5 million Series B investment.

Covalon Technologies Ltd., an advanced medical technologies company, announced that its IV Clear® line of dual antimicrobial silicone dressings has been recommended by physicians at a Top 10 U.S.

Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will host an R&D Event to discuss the pipeline expansion and the evolution of its end-to-end platform on Tuesday, June 20, 2023, at 10:00 am ET.

ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, is excited to announce a new use case for the Information Integration Dilemma solution developed by its subsidiary, BioStrand®.

Biora Therapeutics, Inc., the biotech company that is reimagining therapeutic delivery, announced that it has entered into a definitive agreement for the purchase and sale of 1,509,434 shares of the Company’s common stock at an offering price of $5.30 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules.

X4 Pharmaceuticals announced that it expects to be added to the broad-market Russell 3000 Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the U.S. market opens on June 26, 2023, according to a preliminary list of additions posted on June 9, 2023.

Bionano Genomics, Inc. announced its participation in the International Society for Stem Cell Research Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping for research, development, and manufacturing applications in stem cell therapy.

Avanos Medical, Inc. announced that it will host an Investor Day at Convene on 101 Park Avenue, New York, on Tuesday, June 20th, 2023.

Genflow Biosciences Plc is pleased to announce that, after a successful application process, its Ordinary Shares begin trading on the OTCQB Venture Market in the United States under the symbol GENFF.